Viacell
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Viacell - overview
Established
1994
Location
Cambridge, Massachusetts, US
Primary Industry
Biotechnology
About
ViaCell, Inc. is a US-based biotechnology company, enables the application of human cells as medicine.
Current Investors
Tullis Health Investors, UOB Venture Management, SG Growth Capital, Nomura Asset Management, Genzyme Corp, PerkinElmer U.S. LLC, The Stephens Group, Deutsche Bank
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Viacell - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Viacell | - | ||||||||
| Unspecified Round | Completed | Viacell | - | ||||||||
| Unspecified Round | Completed | Viacell | - | ||||||||
| Venture Debt | Completed | Viacell | - |
Displaying 1 - 4 of 4
Viacell - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.